206 related articles for article (PubMed ID: 30232909)
1. Nomograms to predict survival rates for esophageal cancer patients with malignant behaviors based on ICD-0-3.
Sun Y; Wang J; Li Y; Pan S; Yang T; Sun X; Wang Y; Shi X; Zhao X; Zhang X
Future Oncol; 2019 Jan; 15(2):121-132. PubMed ID: 30232909
[TBL] [Abstract][Full Text] [Related]
2. Development of a Survival Nomogram for Esophageal Squamous Cell Carcinoma Patients: a Population-Based Analysis.
Lu G; Fang W; Lin Y; Huang H
J Gastrointest Cancer; 2024 Mar; 55(1):391-401. PubMed ID: 37804459
[TBL] [Abstract][Full Text] [Related]
3. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
[TBL] [Abstract][Full Text] [Related]
4. Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Chao YK; Chang HK; Tseng CK; Liu YH; Wen YW
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27868287
[TBL] [Abstract][Full Text] [Related]
5. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
6. Nomogram and recursive partitioning analysis to predict overall survival in patients with stage IIB-III thoracic esophageal squamous cell carcinoma after esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang X; Zhou Z; Feng Q; Chen D; Liang J; Fang D; Mao Y; Gao S; Li Y; He J
Oncotarget; 2016 Aug; 7(34):55211-55221. PubMed ID: 27487146
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
[TBL] [Abstract][Full Text] [Related]
9. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
10. Predictive potential of preoperative Naples prognostic score-based nomogram model for the prognosis in surgical resected thoracic esophageal squamous cell carcinoma patients: A retrospective cohort study.
Guo XW; Ji L; Xi XX; Zhao WW; Liu YC; Zhou SB; Ji SJ
Medicine (Baltimore); 2024 May; 103(18):e38038. PubMed ID: 38701277
[TBL] [Abstract][Full Text] [Related]
11. Nomogram for prognosis of patients with esophageal squamous cell cancer after minimally invasive esophagectomy established based on non-textbook outcome.
Xu SJ; Lin LQ; Chen TY; You CX; Chen C; Chen RQ; Chen SC
Surg Endosc; 2022 Nov; 36(11):8326-8339. PubMed ID: 35556169
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
[TBL] [Abstract][Full Text] [Related]
13. Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.
Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
BMC Cancer; 2021 Nov; 21(1):1192. PubMed ID: 34753448
[TBL] [Abstract][Full Text] [Related]
14. [Survival and the value of adjuvant chemotherapy in esophageal squamous cell carcinoma patients with lymphatic metastasis].
Qi Z; Wang YX; Yang Q; Li J; Yao JF; He M
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):628-633. PubMed ID: 28835088
[No Abstract] [Full Text] [Related]
15. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
[TBL] [Abstract][Full Text] [Related]
16. Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis.
Eil R; Diggs BS; Wang SJ; Dolan JP; Hunter JG; Thomas CR
Cancer; 2014 Feb; 120(4):492-8. PubMed ID: 24194477
[TBL] [Abstract][Full Text] [Related]
17. Predicting prognosis in resected esophageal squamous cell carcinoma using a clinical nomogram and recursive partitioning analysis.
Zheng Y; Fu S; He T; Yan Q; Di W; Wang J
Eur J Surg Oncol; 2018 Aug; 44(8):1199-1204. PubMed ID: 29784506
[TBL] [Abstract][Full Text] [Related]
18. A prognostic nomogram for overall survival after neoadjuvant radiotherapy or chemoradiotherapy in thoracic esophageal squamous cell carcinoma: a retrospective analysis.
Deng W; Wang Q; Xiao Z; Tan L; Yang Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Li Y; He J; Gao S; Sun K; Cheng G; Liu X; Fang D; Xue Q; Mao Y; Wang D; Li J
Oncotarget; 2017 Jun; 8(25):41102-41112. PubMed ID: 28456788
[TBL] [Abstract][Full Text] [Related]
19. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
[TBL] [Abstract][Full Text] [Related]
20. Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma.
Hamai Y; Hihara J; Emi M; Furukawa T; Ibuki Y; Yamakita I; Kurokawa T; Okada M
Anticancer Res; 2017 Oct; 37(10):5639-5646. PubMed ID: 28982881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
